Multi-Omic Analyses of Changes in the Tumor Microenvironment of Pancreatic Adenocarcinoma Following Neoadjuvant Treatment with Anti-PD-1 Therapy

Investigators showed that granulocyte-macrophage colony-stimulating factor-secreting allogeneic PDAC vaccine (GVAX)-induced tertiary lymphoid aggregates become immune-regulatory sites in response to GVAX + nivolumab.